amisulpride sandoz pharma amisulpride 400 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride, quantity: 400 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate type a; hypromellose; microcrystalline cellulose; magnesium stearate; lactose monohydrate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride sandoz 200 amisulpride 200 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride sandoz 400 amisulpride 400 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride sandoz 100 amisulpride 100 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride -
amisulpride 400 winthrop amisulpride 400 mg tablet blister pack
sanofi-aventis australia pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: magnesium stearate; sodium starch glycollate type a; peg-40 stearate; lactose monohydrate; titanium dioxide; hypromellose; microcrystalline cellulose - the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
amisulpride eg 200 mg tabl.
eg sa-nv - amisulpride 200 mg - tablet - 200 mg - amisulpride 200 mg - amisulpride
apo-amisulpride
apotex nz ltd - amisulpride 400mg; - film coated tablet - 400 mg - active: amisulpride 400mg excipient: basic butylated methacrylate copolymer isopropyl alcohol lactose monohydrate macrogol 6000 magnesium stearate methylcellulose microcrystalline cellulose purified talc purified water sodium starch glycolate titanium dioxide - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
apo-amisulpride
apotex nz ltd - amisulpride 100mg; - tablet - 100 mg - active: amisulpride 100mg excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
apo-amisulpride
apotex nz ltd - amisulpride 50mg; - tablet - 50 mg - active: amisulpride 50mg excipient: lactose monohydrate magnesium stearate methylcellulose microcrystalline cellulose sodium starch glycolate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
pharmacor amisulpride amisulpride 200 mg uncoated tablet blister pack
southern cross pharma pty ltd - amisulpride -